Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi,Nathalia D’Agustini,Solange C. Garcia,Silvia S. Guterres,Paula R. Pohlmann,Daniela D. Rosa,Adriana R. Pohlmann
Drug Safety.2022;45(6)601
[DOI]
2Prophylactic and Ameliorative Effect of N-Acetylcysteine on Doxorubicin-Induced Neurotoxicity in Wister Rats
Walaa I. Mohammed,Rania A. Radwan,Hoda M. Elsayed
Egyptian Journal of Basic and Clinical Pharmacology.2019;9(6)601
[DOI]
3Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho,Mariana Ferreira,Rita Ferreira,Maria de Lourdes Bastos,Susana Isabel Sá,João Paulo Capela,Félix Carvalho,Vera Marisa Costa
Archives of Toxicology.2022;96(1)11
[DOI]
4Carissa macrocarpa Leaves Polar Fraction Ameliorates Doxorubicin-Induced Neurotoxicity in Rats via Downregulating the Oxidative Stress and Inflammatory Markers
Mohamed A. A. Orabi,Heba M. A. Khalil,Mohamed E. Abouelela,Dalia Zaafar,Yasmine H. Ahmed,Reham A. Naggar,Hamad S. Alyami,El-Shaymaa Abdel-Sattar,Katsuyoshi Matsunami,Dalia I. Hamdan
Pharmaceuticals.2021;14(12)1305
[DOI]
  Feedback 
  Subscribe